RP 59500, a streptogramin derivative, is effective in murine listeriosis

Journal of Chemotherapy

Volumn 8, Issue 2, 1996, Pages 107-112

  Nichterlein, T ^a   Kretschmar, M ^a   Hof, H ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Infection; Listeria monocytogenes; RP 59500

Indexed keywords

AMPICILLIN; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; GENTAMICIN; STREPTOGRAMIN;

ANIMAL EXPERIMENT; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; FEMALE; IN VITRO STUDY; IN VIVO STUDY; LISTERIA MONOCYTOGENES; LISTERIOSIS; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN;

EID: 0029871331     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.1996.8.2.107     Document Type: Article

References (14)

1. Aumercier M, Bouhallab S, Capmau ML, Le Goffic F. KP 59500: a proposed mechanism for its bactericidal activity. J Antimicrob Chemother 1992; 30: (Suppl A): 9-14.
2. Sahm DF, Washington JA. Antibacterial susceptibility tests: dilution methods. In: Balows A, Hausler WJ, Herrmann KL, Isenberg HD, Shadomy HJ, eds. Manual of clinical microbiology. Washington, D.C.: American Society for Microbiology, 1991: 1105-1116.
3. Nichterlein T, Bauer J, Hof, H. Clarithromycin is superior to erythromycin in a tissue culture model of infection with Listeria monocytogenes. Med Microbiol Lett 1992; 1: 85-90.
4. Peterson LR, Shanholtzer CJ. Tests for bactericidal effects of antimicrobial agents: technical performance and clinical relevance. Clin Microbiol Rev 1992; 5: 420-432.
5. Armstrong D. Listeria monocytogenes. In: Mandell GL, Douglas RG, Bennett JE, eds. Principles and practice of infectious diseases, New York: Churchill Livingstone, 1990: 1587-1593.
6. Portnoy DA. Innate immunity to a facultative intracellular bacterial pathogen. Curr Opin Immunol 1992; 4: 20-24.
7. Skogberg K, Syrjänen J, Jahkola M, Renkonen OV, Paavonen J, Ahonen J, Kontiainen S, Ruutu P, Valtonen V. Clinical presentation and outcome of listeriosis in patients with and without immunosuppressive therapy. Clin Infect Dis 1992; 14: 815-821.
8. McLauchlin J, Audurier A, Taylor AG. Treatment failure and recurrent human listeriosis. J Antimicrob Chemother 1991; 27: 851-857.
9. Jones EM, MacGowan AP. Antimicrobial chemotherapy of human infection due to Listeria monocytogenes. Eur J Clin Microbiol Infect Dis 1995; 14: 165-175.
10. Brumfitt W, Hamilton-Miller JM, Shah S. In-vitro activity of RP 59500, a new semisynthetic streptogramin antibiotic, against gram-positive bacteria. J Antimicrob Chemother 1992; 30 (Suppl A): 29-37.
11. Steele-Moore L, Berg D, Furness K, Reinhardt JF, Holloway W. In vitro evaluation of eight antimicrobial agents against clinical isolates of Corynebacterium jeikeium and Listeria monocytogenes. 2nd International Conference on the macrolides, azalides and streptogramins, Venice, Jan 19-22, 199-4, Abstr. 131.
12. Fantin B, Leclercq R, Merlé Y, Saint-Julien L, Veyrat C, Duval J, Carbon C. Critical influence of resistance to streptogramin B-type antibiotics and activity of RP 59500 (Quinupristin-Dalfopristin) in experimental endocarditis due to Staphylococcus aureus. Antimicrob Agents Chemother 1995; 39: 400-405.
13. Desnottes JF, Diallo N. Cellular uptake and intracellular bactericidal activity of RP 59500 in murine macrophages. J Antimicrob Chemother 1992; 30 (Suppl A): 107-115.
14. Van den Broek PJ. Antibiotics and phagocytic cells. In: Raoult, D. ed. Antimicrobial Agents and Intracellular Pathogens, Boca Raton, CRC Press, 1993; 2-22.